About Halozyme Therapeutics

Sponsor retains sole responsibility for content

Halozyme is a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapies that target the tumor microenvironment. Our lead proprietary program, investigational drug PEGPH20 (pegvorhyaluronidase alfa), applies a unique approach to targeting solid tumors, potentially providing increased immune response and tumor access for co-administered anti-cancer therapi...

Halozyme is a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapies that target the tumor microenvironment. Our lead proprietary program, investigational drug PEGPH20 (pegvorhyaluronidase alfa), applies a unique approach to targeting solid tumors, potentially providing increased immune response and tumor access for co-administered anti-cancer therapies.

Contact Halozyme Therapeutics

Phone Number
858.794.8889

More About Halozyme Therapeutics

Therapeutic Areas
  • Oncology
Technologies
  • Other
Company Type
  • Biotechnology – R&D services
State of Ownership
  • Private
Sponsorship Group
  • Networker